Mitchell A. deLong,Jill Marie Sturdivant,Susan M. Royalty
申请号：
US16712186
公开号：
US20200223818A1
申请日:
2019.12.12
申请国别(地区):
US
年份:
2020
代理人:
摘要：
Disclosed are beta and gamma-amino isoquinoline amide compounds and substituted benzamide compounds. In particular, the invention provides compounds that affect the function of kinases in a cell and that are useful as therapeutic agents or with therapeutic agents. The compounds of the invention are useful in the treatment of a variety of diseases and conditions including eye diseases such as glaucoma, cardiovascular diseases, and diseases characterized by abnormal growth, such as cancers. The invention further provides compositions containing the beta or gamma-amino isoquinoline amide compounds or substituted benzamide compounds.
